V. Nagy N, Farkas K, Kemeny L, Szell M. Knowledge explosion for monogenic skin diseases.
INTRODUCTION
Incidence of rare diseases is 1:2000 or less as defined by the European Union. They can impair the life quality of the patient significantly and they can also result in stigmatization and difficulties in socialization. Rare diseases are usually monogenic, meaning that one defined genetic alteration, one gene defect and consequently failure of one protein can be critical and can lead to the development of the disease. In my thesis, I have summarized the results of my genetic investigations in rare, very stigmatizing diseases: LEOPARD syndrome (LS), multiple familial trichoepithelioma type 1 (MFT1), familial cylindromatosis (FC) and Brooke-Spiegler syndrome (BSS).
LEOPARD syndrome
LEOPARD syndrome (MIM 151100) is an autosomal dominant condition belonging to the family of neuro-cardiofacio-cutaneous syndromes. The name is an acronym of its major features such as multiple Lentigines, Electrocardiographic conduction abnormalities, Ocular hypertelorism, Pulmonary stenosis, Abnormal genitalia, Retardation of growth and sensorineural Deafness. LS is the consequence of mutations located in the protein-tyrosine phosphatase nonreceptor-type 11 (PTPN11) gene
Multiple familial trichoepithelioma type 1
Multiple familial trichoepithelioma type 1 (MIM 601606) is an autosomal dominant condition characterized by numerous firm skin-colored papules that are trichoepitheliomas.
Trichoepitheliomas are small benign skin-colored tumors and are typically present at the center of the face, mostly around the nose, periorbitally and in the nasolabial.
Familial cylindromatosis
Familial cylindromatosis (MIM132700) is also an autosomal dominantly inherited disorder. Patients with FC have cylindromas, which are slowly growing benign tumors that are usually located on the scalp and face. Typically, they appear as multiple turban-like protrusions on the scalp, which are also referred as turban tumors.
Brooke-Spiegler syndrome
Brooke-Spiegler syndrome (MIM 605041) is also a rare monogenic skin disease characterized by the development of a wide variety of benign skin appendage tumors, such as trichoepitheliomas, cylindromas and/or spiradenomas. Spiradenomas are purple benign nodular tumors, which are usually located on the trunk or limbs.
MFT1, FC and BSS have been independently mapped to chromosome 16q12-q13. In the mapped region, the cylindromatosis (CYLD) gene was identified as the causative gene responsible for the development of these three diseases. MFT1, FC and BSS were originally described as distinct clinical entities, but due to their overlapping clinical symptoms and their manifestation within the same families, they are now considered as clinical variants that represent a phenotypic spectrum of a single entity.
AIMS
In my thesis, the primary aim was to summarize the results of the genetic and functional investigations in stigmatizing rare monogenic disorders, as LS caused by PTPN11 gene mutations and the clinical variants of the CYLD mutation-caused disease spectrum such as BSS, FC and MFT1.
Concerning LS, the aim was to identify the underlying causative genetic abnormality in a 51-year-old Hungarian male patient. Besides, it was also among my goals to compare this variant with the reported ones in the literature in order to define genotype-phenotype correlations and Hungarian population specific mutations.
Regarding CYLD mutation-caused disease spectrum, my aim was to investigate families and sporadic cases affected by MFT1, FC or BSS in order to identify the underlying genetic abnormalities. I have also aimed to perform further genetic investigations including haplotype analysis to demonstrate whether different cases and families affected by different clinical variants of the CYLD mutation-caused disease spectrum carrying the same CYLD mutation are the consequence of the same founder event or independent mutational events. In case of novel mutations, I have also aimed to perform functional investigations to prove their ability to impair the function of the encoded CYLD enzyme. Besides these investigations, my further goals were to describe genotype-phenotype correlations and population specific mutation database. 
PATIENTS AND METHODS

Hungarian pedigree affected by LEOPARD syndrome
The investigated 51-year-old Hungarian male patient has the typical symptoms of LS including facial anomalies, pigmentation abnormalities, cardiovascular and urological symptoms. The patient is deaf and dumb and mild growth as well as mental retardations were also present. The patient was born out of wedlock. There are no any other clinically affected relatives either on his father, or on his mother side.
Spanish pedigree affected by multiple familial trichoepithelioma type 1
The 62-year-old Spanish male has multiple skin-colored papules in both nasolabial folds, on the forehead, above the eyebrows and, to a lesser extent, on the ears, on the back of the head and on the back. The patient's only child, a 33-year-old daughter, has lesions similar to those of her father but are fewer in number. The lesions first appeared in both nasolabial folds and, over time, began to appear on her forehead, temples, ears and scalp. No other clinically affected member has been identified in this pedigree.
Dutch patients affected by familial cylindromatosis
The investigated Dutch patients were previously reported by Van den Ouweland et al.
Austrian patient affected by Brooke-Spiegler syndrome
The investigated Austrian patient was previously reported by Grossmann et al.
Hungarian pedigree from Szekszárd affected by Brooke-Spiegler syndrome
21 affected family members were identified in the seven-generation BSS family in Hungary. The affected individuals have serious skin appendage tumors. Some of them have cylindromas on the scalp and trichoepitheliomas on the face. The tumors appeared on the back and on the extremities of the patients.
Anglo-Saxon pedigree affected by Brooke-Spiegler syndrome
The Anglo-Saxon pedigree contained 8 affected family members spanning five generations. The affected individuals had a comparatively milder phenotype, with cylindromas and spiradenomas on the scalp and trichoepitheliomas on the face. 
Hungarian pedigree from Szeged affected by Brooke-Spiegler syndrome
A Hungarian pedigree suffering from BSS has 2 affected and 5 unaffected individuals spanning two generations. One of the affected individuals, a 60-year-old male has numerous soft, hairless, skin-colored papules around his nose, in his ears, on his scalp and on his shoulders. His daughter, a 35-year-old female presented with milder symptoms.
Methods
Peripheral blood samples were taken from the affected and unaffected family members as well as from healthy controls for genetic analysis. Genomic DNA was isolated and after the amplification of the coding regions and the flanking introns of the investigated gene, DNA sequencing was performed. For the haplotype analysis, common polymorphisms located in the 3' and 5' prime region of the identified mutation were genotyped using direct sequencing. For functional analysis after immunoprecipitation Western blot was performed.
RESULTS
Genetic investigation of the PTPN11 gene
In case of LS patient, direct sequencing of the coding regions and the flanking introns of the PTPN11 gene revealed a missense mutation (c.836A/G; p.Tyr279Cys) in the seventh exon. The clinically affected LS patient carried one of the most common missense mutation of the PTPN11 gene in heterozygous form, while the unrelated healthy controls carried the wild type sequence.
Genetic, haplotype and functional investigations of the CYLD gen
Genetic investigation of the Spanish pedigree
Direct sequencing of the coding regions (exon 9-20) and the flanking introns of the CYLD gene revealed a previously described nonsense mutation (c.2272C/T, p.Arg758X) in exon 17. Both investigated patients carried the mutation in heterozygous form, whereas the unaffected family members and the unrelated controls carried the wild-type sequence.
Haplotype analysis of the Spanish pedigree, the Dutch and the Austrian patients
Previously reported Dutch and Austrian cases carry the same mutation that was identified in the Spanish pedigree (c.2272C/T, p.Arg758X Thus, it can be assumed that different mutational events are responsible for the development of the Austrian case and the Spanish and Dutch cases.
Genetic investigation of the Hungarian pedigree from Szekszárd
Direct sequencing of the coding regions and the flanking introns of the CYLD gene revealed a previously described nonsense mutation (c.2806C>T, p.Arg936X) in exon 20. The investigated affected family members carried the mutation in heterozygous form, while the clinically unaffected family members and the unrelated healthy controls carried the wild type sequence.
Haplotype analysis of the Hungarian pedigree from Szekszárd and the Anglo-
Saxon pedigree
An Anglo-Saxon BSS pedigree also carried the same nonsense mutation (c.2806C>T, p.Arg936X), that was identified the Hungarian pedigree from Szekszárd.
Haplotype analysis was performed to reveal whether the mutation they carry is the result of two independent mutational events or they are carrying the same founding mutation. As the result of the haplotype analysis, in case of the Hungarian pedigree, two polymorphisms were found, which were inherited linked to the mutation in the CYLD gene. The haplotype of the Anglo-Saxon pedigree was different, which means that the same nonsense mutation was the result of two independent mutational events in the two pedigrees. Thus this part of the CYLD gene could be a mutational hotspot.
Genetic investigation of the Hungarian pedigree from Szeged
Mutation analysis of the CYLD gene revealed a novel missense mutation (c.2613C>G p.His871Gln) located in exon 19, in heterozygous form in the investigated affected patients. This mutation could not be identified in any of the clinically unaffected family members or in the healthy controls. (40%) patients. The p.Tyr279Cys mutation is rarely associated with deafness, which was reported in 12 (25%) patients. This analysis identified that certain symptoms -such as cryptorchidism, macrocephaly, horse kidney, hydrothorax, myelodysplasia and umbilical hernia -are rarely associated with the p.Tyr279Cys phenotype. The observed differences in the clinical symptoms of the 48 LS patients carrying the same missense mutation clearly demonstrate the wide phenotypic diversity and the variable expressivity of the disease.
Haplotype analysis of the patients carrying the recurrent nonsense p.Arg758X
CYLD mutation represents a mutational hotspot in the gene
In case of a Spanish MFT1 pedigree with two affected family members (father and daughter), direct sequencing of the CYLD gene revealed a recurrent nonsense mutation (c.2272C/T, p.Arg758X) in exon 17. The p.Arg758X nonsense mutation has also been detected in patients with BSS, FC and MFT1. Furthermore, this mutation has been detected in different ethnic groups including Dutch and Austrian. Previously reported Dutch and Austrian cases carrying the same mutation were also investigated. To determine whether the worldwide recurrent p.Arg758X mutation of the CYLD gene is the result of one or more independent mutational events, haplotype analysis was performed. The haplotype analysis of the Spanish, Dutch and Austrian patients demonstrated that, although the Spanish and the Dutch patients carry the same haplotype, the clinical appearance, MFT1 and FC, respectively, is different.
These results suggest the importance of modifying genetic and/or environmental factors. In contrast with these, the Austrian patient carried a different haplotype than the Spanish and Dutch families. Thus, presumably the presence of the same mutation is the consequence of different mutational events. These data suggest that the p.Arg758X nonsense mutation is located at a mutational hotspot in the CYLD gene.
Haplotype analysis of the patients carrying the recurrent nonsense p.Arg936X
CYLD mutation represents a mutational hotspot in the gene
A large Hungarian BSS pedigree carrying a nonsense mutation (c.2806C>T, p.Arg936X) of the CYLD gene was investigated. This nonsense p.Arg936X mutation was also present in an Anglo-Saxon BSS pedigree, therefore haplotype analysis was performed to elucidate whether the mutation they carry is the result of the same or two independent mutational events. Haplotype analysis of the Hungarian and the Anglo-Saxon BSS pedigrees demonstrated that the same mutation carried by the two geographically distant pedigrees was the result of two independent mutational events. I hypothesize that these positions may be mutational hotspots on the CYLD gene.
The functional analysis of the newly identified missense mutation represents a disease causing mutation in the CYLD gene
A novel missense mutation (c.2613C>G, p.His871Gln) of CYLD gene was identified in a Hungarian BSS pedigree. CYLD protein has a role in the regulation of many signaling pathways, such as NF-κB signaling pathway throuhg the deubiquitination of NEMO protein 11 as its interaction partner. Ubiquitination of NEMO was investigated and based on the results presumably this novel mutation through the increased ubiquitination of NEMO leads to decreased NEMO expression and as a consequence may influence the NF-κB pathway.
Further studies are needed to elucidate the exact mechanism of the development of BSS symptoms. Analyzes have been performed to reveal the functional role of this novel mutation. Data suggest that this novel CYLD mutation leads to increased ubiquitination of NEMO through influencing deubiquitinating activity of the CYLD protein and thus may result in enhanced NF-κB signaling.
Mutations on the
These investigations have great importance because they could be the basis of future genetic studies for the development of novel causative therapies that will be more specific and effective than the symptomatic treatments. Genetic screening and the identification of the disease-causing mutation have great significance for family planning in prenatal and preimplantation diagnosis.
